A detailed history of Gainplan LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Gainplan LLC holds 22,700 shares of OCGN stock, worth $17,252. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,700
Previous 23,623 3.91%
Holding current value
$17,252
Previous $23,000 21.74%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$0.72 - $1.08 $664 - $996
-923 Reduced 3.91%
22,700 $18,000
Q2 2024

Jul 12, 2024

BUY
$1.18 - $1.98 $11,402 - $19,132
9,663 Added 69.22%
23,623 $36,000
Q1 2024

Apr 25, 2024

BUY
$0.5 - $1.83 $6,980 - $25,546
13,960 New
13,960 $22,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $165M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Gainplan LLC Portfolio

Follow Gainplan LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gainplan LLC with notifications on news.